Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester

BMJ Case Reports

Volumn , Issue , 2010, Pages

  Bayraktar, Soley ^a   Morency, Belline ^b   Escaloń, Maricer P ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879261794     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.05.2010.2975     Document Type: Article

References (29)

1. Redaelli A, Bell C, Casagrande J, et al. Clinical and epidemiologic burden of chronic myelogenous leukemia. Expert Rev Anticancer Ther 2004; 4: 85-96. [CrossRef] [Medline] (Pubitemid 38208489)
2. Fauci, Braunwald, Isselbacher, Wilson Wetzler M, Bloomfield CD. Acute and chronic myeloid leukemia. In: Fauci, Braunwald, Isselbacher, Wilson, eds. Harrison's Principles of Internal Medicine. 17th Edition. Vol I. 2008: 677-86. Search Google Scholar
3. Nowell PC, Hungerford DA. A minute chromosome in human granulocytic leukemia. Science 1960; 132: 1488-501. [FREE Full text]
4. Nowell PC, Hungerford DA. Chromosome studies in human leukemia. II. Chronic granulocytic leukemia. J Natl Cancer Inst 1961; 27: 1013-35. [Medline] [Web of Science]
5. O'Brien SG, Guilhot F, Larson RA, et al.; IRIS Investigators. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994-1004. [CrossRef] [Medline] [Web of Science] (Pubitemid 36302244)
6. Druker BJ, Guilhot F, O'Brien SG, et al.; IRIS Investigators. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408-17. [CrossRef] [Medline] [Web of Science] (Pubitemid 44903745)
7. NCCN. NCCN Clinical Practice Guidelines in Oncology: Chronic Myelogenous Leukemia. PA Fort Washington: NCCN 2009.
8. Savona M, Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer 2008; 8: 341-50. [CrossRef] [Medline] [Web of Science] (Pubitemid 351589698)
9. Advani AS, Pendergast AM. Bcr-Ablvariants: biological and clinical aspects. Leuk Res 2002; 26: 713-20. [CrossRef] [Medline] [Web of Science]
10. Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-3. [CrossRef] [Medline] [Web of Science]
11. Kantarjian HM, Giles F, Quintás-Cardama A, et al. Important therapeutic targets in chronic myelogenous leukemia. Clin Cancer Res 2007; 13: 1089-97. [Abstract/FREE Full text] (Pubitemid 46424047)
12. Hochhaus A, Baccarani M, Deininger M, et al. Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia 2008; 22: 1200-6. [CrossRef] [Medline] [Web of Science] (Pubitemid 351833788)
13. Cortes J, Kim DW, Raffoux E, et al. Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase. Leukemia 2008; 22: 2176-83. [CrossRef] [Medline] [Web of Science]
14. Cortes J, O'Brien S, Borthakur G, et al. Efficacy of dasatinib in patients with previously untreated chronic myelogenous leukemia (CML) in early chronic phase (CMLCP). Blood 2008; 112: Abstract 182. Search Google Scholar
15. Klaasen R, de Jong P, Wijermans PW. Successful management of chronic myeloid leukaemia with leucapheresis during a twin pregnancy. Neth J Med 2007; 65: 147-9. [Medline] [Web of Science] (Pubitemid 46656853)
16. Celiloglu M, Altunyurt S, Undar B. Hydroxyurea treatment for chronic myeloid leukemia during pregnancy. Acta Obstet Gynecol Scand 2000; 79: 803-4. [CrossRef] [Medline] [Web of Science]
17. Baer MR, Ozer H, Foon KA. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol 1992; 81: 167-9. [Medline] [Web of Science]
18. GLEEVEC (imatinib mesy late) [Important Safety Information]. NNPC: East Hanover, 2001.
19. Tasigna (nilotinib) [Important Safety Information]. NNPC: East Hanover, 2007.
20. Sprycel (dasatinib) [Important Safety Information]. NB-MS: Princeton, 2007.
21. Ault P, Kantarjian H, O'Brien S, et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol 2006; 24: 1204-8. [Abstract/FREE Full text] (Pubitemid 46638819)
22. Pye SM, Cortes J, Ault P, et al. The effects of imatinib on pregnancy outcome. Blood 2008; 111: 5505-8. [Abstract/FREE Full text]
23. Cole S, Kantarjian H, Ault P, et al. Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature. Clin Lymphoma Myeloma 2009; 9: 324-7. [CrossRef] [Medline] [Web of Science]
24. Klamová H, Marková M, Moravcová J, et al. Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery. Leuk Res 2009; 33: 1567-9. [CrossRef] [Medline] [Web of Science]
25. He K, Lago MW, Iyer RA, et al. Lacteal secretion, fetal and maternal tissue distribution of dasatinib in rats. Drug Metab Dispos 2008; 36: 2564-70. [Abstract/FREE Full text]
26. Conchon M, Sanabani SS, Serpa M, et al. Successful pregnancy and delivery in a patient with chronic myeloid leukemia while on Dasatinib therapy. Adv Hematol 2010:1-4. Search Google Scholar
27. Oweini H, Otrock ZK, Mahfouz RA, et al. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib. Arch Gynecol Obstet 2010. doi: 10.1007/s00404-010-1501-6 Search Google Scholar
28. Cortes J, O'Brien S, Ault P, et al. Pregnancy outcomes among patients with chronic myeloid leukemia treated with Dasatinib. Blood 2008; 112: Abstract 323. Search Google Scholar
29. Conchon M, Sanabani SS, Bendit I, et al. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study. J Hematol Oncol 2009; 2: 42. [CrossRef] [Medline]